Prognostic significance of systemic inflammatory response markers in patients with superficial esophageal squamous cell carcinomas

被引:0
作者
Chi-Jen Chen
Ching-Tai Lee
Ying-Nan Tsai
Chao-Ming Tseng
Tzu-Haw Chen
Ming-Hung Hsu
Chih-Chun Wang
Wen-Lun Wang
机构
[1] E-Da Hospital/I-Shou University,Department of Internal Medicine
[2] E-Da Cancer Hospital,Department of Internal Medicine
[3] E-Da Hospital/I-Shou University,Department of Otolaryngology
[4] I-Shou University,School of Medicine, College of Medicine
来源
Scientific Reports | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Endoscopic resection or esophagectomy has becoming the standard treatment for superficial esophageal squamous cell carcinomas (SESCC), but some patients may develop disease progression or second primary cancers after the therapies. Neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), and platelet to lymphocyte ratio (PLR) reflect the balance between pro-cancer inflammatory and anti-cancer immune responses, however their roles in SESCC are still unknown. We consecutively enrolled patients with newly diagnosed SESCC (clinical stage Tis or T1N0M0) who were treated at our institute. Pre-treatment NLR, LMR and PLR were assessed and then correlated with clinical factors and long-term survival. A total of 156 patients were enrolled (152 males, 4 females; median age: 52.2 years), of whom 104 received endoscopic resection and 52 were treated with esophagectomy or chemoradiation.. During a mean follow-up period of 60.1 months, seventeen patients died of ESCCs, and 45 died of second primary cancers. The 5-year ESCC-specific survival and 5-year overall survival rate were 86% and 57%, respectively. LMR (P < 0.05) and NLR (P < 0.05), but not PLR were significantly correlated with overall survival. Receiver operating characteristic curve analysis showed optimal LMR and NLR cut-off values of 4 and 2.5, respectively, to predict a poor prognosis. Patients with a high NLR or low LMR tended to have longer tumor length, larger circumferential extension, and presence of second primary cancers. Multivariate Cox regression analysis showed that presence of second primary cancers (HR: 5.05, 95%CI: 2.75–9.28), low LMR (HR: 2.56, 95%CI: 1.09–6.03) were independent risk factors for poor survival. A low pre-treatment LMR may be a non-invasive pretreatment predictor of poor prognosis to guide the surveillance program, suggesting that anti-cancer immunity may play a role in the early events of esophageal squamous cancer.
引用
收藏
相关论文
共 72 条
[1]  
Barret M(2018)Diagnosis and treatment of superficial esophageal cancer Ann. Gastroenterol. 31 256-265
[2]  
Prat F(2015)Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 Int. J. Cancer 136 E359-E386
[3]  
Ferlay J(2015)Global incidence of oesophageal cancer by histological subtype in 2012 Gut 64 381-387
[4]  
Arnold M(2017)Screening and prevention strategies and endoscopic management of early esophageal cancer Chin. Clin. Oncol. 6 50-1572
[5]  
Soerjomataram I(2010)Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: A multicenter randomized controlled trial J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 28 1566-112
[6]  
Ferlay J(2017)Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: Magnifying endoscopic classification of the Japan esophageal society Esophagus Off. J. Japan Esophageal Soc. 14 105-968
[7]  
Forman D(2020)Long-term outcomes of endoscopic submucosal dissection and comparison to surgery for superficial esophageal squamous cancer: A systematic review and meta-analysis Therap. Adv. Gastroenterol. 13 1756284820964316-1296
[8]  
Kim JA(2021)Systematic review and meta-analysis of the most common genetic mutations in esophageal squamous cell carcinoma J. Gastrointest. Cancer 6 963-309
[9]  
Shah PM(1953)Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin Cancer 122 1291-866
[10]  
Muto M(2012)Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma Laryngoscope 41 304-1468